Franklin Resources Inc. Grows Position in Prestige Consumer Healthcare Inc. (NYSE:PBH)

Franklin Resources Inc. raised its holdings in shares of Prestige Consumer Healthcare Inc. (NYSE:PBHFree Report) by 9.6% during the 4th quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 20,057 shares of the company’s stock after purchasing an additional 1,764 shares during the quarter. Franklin Resources Inc.’s holdings in Prestige Consumer Healthcare were worth $1,228,000 as of its most recent filing with the Securities & Exchange Commission.

Other institutional investors have also added to or reduced their stakes in the company. Truist Financial Corp lifted its holdings in Prestige Consumer Healthcare by 54.1% during the fourth quarter. Truist Financial Corp now owns 6,558 shares of the company’s stock valued at $401,000 after purchasing an additional 2,302 shares during the last quarter. Norges Bank purchased a new stake in Prestige Consumer Healthcare during the fourth quarter valued at about $27,739,000. Trexquant Investment LP lifted its holdings in Prestige Consumer Healthcare by 109.1% during the third quarter. Trexquant Investment LP now owns 8,340 shares of the company’s stock valued at $477,000 after purchasing an additional 4,351 shares during the last quarter. Qube Research & Technologies Ltd lifted its holdings in Prestige Consumer Healthcare by 91.4% during the third quarter. Qube Research & Technologies Ltd now owns 72,092 shares of the company’s stock valued at $4,123,000 after purchasing an additional 34,430 shares during the last quarter. Finally, Connors Investor Services Inc. purchased a new stake in shares of Prestige Consumer Healthcare in the third quarter worth about $1,569,000. 99.95% of the stock is owned by hedge funds and other institutional investors.

Prestige Consumer Healthcare Stock Up 0.9 %

PBH stock opened at $64.82 on Thursday. The company has a current ratio of 3.20, a quick ratio of 2.02 and a debt-to-equity ratio of 0.68. The company’s 50 day moving average is $68.20 and its 200 day moving average is $65.73. The stock has a market cap of $3.24 billion, a price-to-earnings ratio of 15.54, a price-to-earnings-growth ratio of 1.81 and a beta of 0.50. Prestige Consumer Healthcare Inc. has a 1-year low of $56.25 and a 1-year high of $75.31.

Prestige Consumer Healthcare (NYSE:PBHGet Free Report) last posted its quarterly earnings data on Tuesday, May 14th. The company reported $1.02 earnings per share for the quarter, missing the consensus estimate of $1.14 by ($0.12). The company had revenue of $277.00 million during the quarter, compared to the consensus estimate of $287.42 million. Prestige Consumer Healthcare had a return on equity of 13.48% and a net margin of 18.60%. The firm’s revenue for the quarter was down 3.1% on a year-over-year basis. During the same quarter last year, the company posted $1.07 earnings per share. Sell-side analysts predict that Prestige Consumer Healthcare Inc. will post 4.41 EPS for the current fiscal year.

Analyst Ratings Changes

A number of equities research analysts have recently issued reports on the stock. StockNews.com downgraded shares of Prestige Consumer Healthcare from a “strong-buy” rating to a “buy” rating in a report on Tuesday, May 21st. DA Davidson reissued a “neutral” rating and issued a $65.00 price target on shares of Prestige Consumer Healthcare in a report on Thursday, May 16th. TheStreet raised shares of Prestige Consumer Healthcare from a “c+” rating to a “b-” rating in a report on Monday, February 12th. Finally, Canaccord Genuity Group reissued a “buy” rating and issued a $80.00 price target on shares of Prestige Consumer Healthcare in a report on Tuesday, May 21st. Two research analysts have rated the stock with a hold rating and three have assigned a buy rating to the stock. According to data from MarketBeat.com, Prestige Consumer Healthcare presently has an average rating of “Moderate Buy” and an average price target of $91.25.

Get Our Latest Stock Report on PBH

Prestige Consumer Healthcare Company Profile

(Free Report)

Prestige Consumer Healthcare Inc, together with its subsidiaries, develops, manufactures, markets, distributes, and sells over-the-counter (OTC) health and personal care products in the United States and internationally. The company operates in two segments, North American OTC Healthcare and International OTC Healthcare.

Featured Articles

Institutional Ownership by Quarter for Prestige Consumer Healthcare (NYSE:PBH)

Receive News & Ratings for Prestige Consumer Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Prestige Consumer Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.